Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat

Summary

The purpose of this research study is to learn about the effect of Liraglutide (Victoza) on the fat of the heart and some fat cells in blood.

Timeline

Start

2020-09-01

Primary completion

2021-09-01

Completion

2021-12-31

Outcome

Outcome not reported

Stopped (Business): “Lack of funds to cover the costs of the study medications”

Drugs

Indications